Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

Walker, Z.; Costa, D. C.; Walker, R. W. H.; Shaw, K.; Gacinovic, S.; Stevens, T.; Livingston, G.; Ince, P.; McKeith, I. G.; Katona, C. L. E.
August 2002
Journal of Neurology, Neurosurgery & Psychiatry;Aug2002, p134
Academic Journal
No abstract available.


Related Articles

  • The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Cummings, Jeffrey L.; Henchcliffe, Claire; Schaier, Sharon; Simuni, Tanya; Waxman, Alan; Kemp, Paul // Brain: A Journal of Neurology;Nov2011, Vol. 134 Issue 11, p3146 

    Diagnosis of neurological and psychiatric conditions associated with disturbances of dopaminergic functioning can be challenging, especially in the early stages, and may be assisted with biomarkers such as dopamine system imaging. Distinguishing between Alzheimer’s disease and dementia...

  • Ioflupane I-123 radionuklidinÄ—s kompiuterinÄ—s tomografijos vaizdinimo taikymo galimybÄ—s ekstrapiramidinių sutrikimų ir demencijų diferencinÄ—je diagnostikoje. Kaladytė-Lokominienė, R.; Vajauskas, D.; Sakalauskaitė-Juodeikienė, E. // Neurologijos Seminarai;2011, Vol. 15 Issue 4, p253 

    In strict application of clinical criteria of Parkinson's disease, clinical diagnosis corresponds to histopathological diagnosis in 93 % of cases. Retrospective studies show that a significant number of parkinsonian patients do not receive a distinct clinical diagnosis for at least 5 years....

  • Imaging of the dopaminergic system in differential diagnosis of dementia. Tatsch, Klaus // European Journal of Nuclear Medicine & Molecular Imaging;Mar2008 Supplement, Vol. 35, p51 

    Neurodegenerative dementia is an increasingly common disorder with Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) accounting for most cases. Due to the overlap in clinical symptoms, their differential diagnosis may be challenging. As clinical classification is not completely...

  • Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases. Treglia, Giorgio; Cason, Ernesto; Gabellini, Anna; Giordano, Alessandro; Fagioli, Giorgio // Neurological Sciences;Aug2010, Vol. 31 Issue 4, p417 

    Radiolabeled metaiodobenzylguanidine (MIBG) is an analog of guanethidine and is taken up by the postganglionic presynaptic nerve endings. MIBG uptake in the heart correlates with adrenergic function, which can be reduced in Lewy body diseases. We described the recent developments in innervation...

  • Differentiating Lewy Body Dementia From Alzheimer's, Parkinson's.  // ASHA Leader;Dec2016, Vol. 21 Issue 12, p16 

    The article presents information on a study by Ohio State University on the development of a clinical profile that will assist in identifying and differentiate Lewy body dementia from Alzheimer's and Parkinsons diseases.

  • Functional connectivity in cortical regions in dementia with Lewy bodies and Alzheimer's disease. Kenny, Eva R.; Blamire, Andrew M.; Firbank, Michael J.; O'Brien, John T. // Brain: A Journal of Neurology;Feb2012, Vol. 135 Issue 2, p569 

    Using resting-state functional magnetic resonance imaging, spontaneous low-frequency fluctuations in the blood oxygenation level-dependent signal were measured to investigate connectivity between key brain regions hypothesized to be differentially affected in dementia with Lewy bodies compared...

  • Dementia. Bain, Peter; Blass, John; Wade, John // Current Medical Literature: Neurology;2006, Vol. 22 Issue 3, p85 

    The article provides information on the results of several studies regarding dementia. Patients with dementia with Lewy bodies and Alzheimer's disease could be differentiated through different patterns of activation and deactivation evidence. A purified cannabis derivative drolabinol is...

  • in the clinic: Dementia.  // Annals of Internal Medicine;4/1/2008, Vol. 148 Issue 7, pITC4-1 

    The article discusses the prevention, screening, diagnosis and treatment of dementia. Dementia is described as a decline in cognitive function from baseline and is commonly caused by Alzheimer disease, vascular dementia, Lewy body dementia and frontotemporal dementia. Included are discussions on...

  • How to Distinguish Dementia with Lewy Bodies from Alzheimer Disease? Tiraboschi, Pietro; Guerra, Ugo P. // Open Nuclear Medicine Journal;2010 Special Issue, p58 

    Dementia with Lewy (DLB) bodies is the most common type of degenerative dementia after Alzheimer Disease (AD). Although an accurate diagnosis of DLB is important for adequate prognosis and therapy, its differentiation from other dementias and, especially, from AD may be extremely challenging for...

  • Dementia DDX. Bolla, Leela R.; Filley, Christopher M.; Palmer, Robert M. // Geriatrics;Jan2000, Vol. 55 Issue 1, p34 

    Provides a practical approach to the differential diagnosis of four clinical dementia syndromes. Guidelines and consensus criteria for these dementias; Algorithm to summarize the differential diagnosis and treatment of the major dementias; Patient history and work-up; Alzheimer's disease;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics